Antipruritic efficacy of a high-dosage antihistamine therapy: Results of a retrospectively analysed case series;Antipruritische Wirksamkeit einer hoch dosierten Antihistaminikatherapie : Ergebnisse einer retrospektiv analysierten Fallserie

Hautarzt

Volumn 60, Issue 7, 2009, Pages 564-568

  Schulz, S ^a   Metz, M ^b   Siepmann, D ^a   Luger, T A ^a   Maurer, M ^b   Stander S ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Desloratadin; Itch; Non sedating; Pruritus; Urticaria

Indexed keywords

AZELASTINE; DESLORATADINE; FEXOFENADINE; LEVOCETIRIZINE;

ARTICLE; CHRONIC PRURITUS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; PRURITUS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANTIPRURITICS; CASE-CONTROL STUDIES; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTAMINE ANTAGONISTS; HUMANS; MIDDLE AGED; PRURITUS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 68249097192     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-009-1730-4     Document Type: Article

References (15)

1. Ikoma A, Steinhoff M, Ständer S et al (2006) Neurobiology of pruritus. Nat Rev Neurosci 7:535-547
2. Ständer S, Streit M, Darsow U et al (2006) Leitlinie: Diagnostisches und therapeutisches Vorgehen bei chronischem Pruritus. JDDG 4:350-370
3. Ständer S, Weisshaar E, Luger TA (2008) Neurophysiological and neurochemical basis of modern pruritus treatment. Exp Dermatol 17:161-169
4. Siebenhaar F, Degener F, Zuberbier T et al (2008) Updosing of desloratadine results in better improvement of temperature and exposure time thresholds in patients with cold urticaria. Allergy 63 (Suppl 8):539
5. Zuberbier T, Maurer M (2007) Urticaria: current opinions about etiology, diagnosis and therapy. Acta Derm Venereol 87:196-205
6. Klein PA, Clark RA (1999) An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 135:1522-1525
7. Andoh T, Kuraishi Y (2002) Inhibitory effects of azelastine on substance P-induced itch-associated response in mice. Eur J Pharmacol 436:235-239
8. Amsellem C, Czarlewski W, Lagarde M, Pacheco Y (1998) Inhibitory effect of loratadine on leukotriene B4 production by neutrophils either alone or during interaction with human airway epithelial cells. Pulm Pharmacol Ther 11:245-252
9. Temple DM, McCluskey M (1998) Loratadine, an anti-histamine, blocks antigen- and ionophore-induced leukotriene release from human lung in vitro. Prostaglandins 35:549-554
10. Gelfand EW, Appajosyula S, Meeves S (2004) Anti-inflammatory activity of H1-receptor antagonists: Review of recent experimental research. Curr Med Res Opin 20:73-81
11. Schroeder JT, Schleimer RP, Lichtenstein LM, Kreutner W (2001) Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. Clin Exp Allergy 31:1369-1377
12. Lippert U, Kruger-Krasagakes S, Moller A et al (1995) Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy- loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol 4:272-276
13. Wu P, Mitchell S, Walsh GM (2005) A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions. Clin Exp Allergy 35:1073-1079
14. Vancheri C, Mastruzzo C, Tomaselli V et al (2005) The effect of fexofenadine on expression of intercellular adhesion molecule 1 and induction of apoptosis on peripheral eosinophils. Allergy Asthma Proc 26:292-298
15. Giustizieri ML, Albanesi C, Fluhr J et al (2004) H1 histamine receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol 114:1176-1182